Brighton Jones LLC’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-969
Closed -$236K 305
2017
Q2
$236K Buy
+969
New +$228K 0.03% 230
2016
Q2
Sell
-857
Closed -$230K 216
2016
Q1
$230K Buy
857
+106
+14% +$30.3K 0.04% 181
2015
Q4
$235K Buy
751
+5
+0.7% +$1.49K 0.05% 172
2015
Q3
$203K Buy
+746
New +$229K 0.04% 183

Other funds holding AGN

Brighton Jones LLC's AGN Position: Q3 2017 in Review

Brighton Jones LLC sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 969 shares — an estimated $236K sold.

Brighton Jones LLC first reported a position in AGN in Q3 2015 and held it in 4 quarters. The position peaked at $236K in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Brighton Jones LLC reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Brighton Jones LLC sold 969 Allergan plc shares in Q3 2017, an estimated $236K.
  • Brighton Jones LLC first reported a position in Allergan plc in Q3 2015 and held it in 4 quarters.
  • Brighton Jones LLC's Allergan plc position peaked at $236K in Q2 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Brighton Jones LLC's 13F filing for Q3 2017, filed 8 Nov 2017.